688276 百克生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.090-6.5095.63513.2195.204
总资产报酬率 ROA (%)-0.068-5.1124.52810.7404.293
投入资产回报率 ROIC (%)-0.083-6.2135.54813.1645.189

边际利润分析
销售毛利率 (%)80.95173.43585.42290.23387.193
营业利润率 (%)-5.208-54.92320.98230.65117.445
息税前利润/营业总收入 (%)-4.715-54.71620.50330.22516.574
净利润/营业总收入 (%)-2.358-43.39718.88327.45716.943

收益指标分析
经营活动净收益/利润总额(%)41.96772.837117.164113.717128.993
价值变动净收益/利润总额(%)135.47610.369-0.1720.1220.156
营业外收支净额/利润总额(%)-1.729-0.127-0.8270.7925.452

偿债能力分析
流动比率 (X)1.2821.2882.1422.2122.872
速动比率 (X)1.0451.0831.9562.0162.603
资产负债率 (%)25.01124.02118.96520.33016.902
带息债务/全部投入资本 (%)7.2225.5442.2230.2700.076
股东权益/带息债务 (%)1,268.5831,682.3884,388.11836,887.943130,705.826
股东权益/负债合计 (%)299.830316.307427.278391.895491.638
利息保障倍数 (X)-11.664-397.447-66.861-45.043-8.828

营运能力分析
应收账款周转天数 (天)568.287696.855434.859249.781291.029
存货周转天数 (天)801.737444.951371.489395.045568.563